To investigate the prospective roles and the clinicopathological application of microRNA-21-5p (miR-21-5p) in hepatocellular carcinoma (HCC), the present review is based on 24 studies and bioinformatics investigation. Firstly, HCC-associated miR-21-5p data were aggregated from literature databases and two public genomic data repositories, including the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). Potential target genes of miR-21-5p in HCC were identified using TCGA and GEO, Natural Language Processing and 14 online software packages. The oncogenic roles of these target genes was probed for understanding using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis. Hub genes were further investigated by protein-protein interaction network (PPI) analysis. Comprehensive meta-analysis, including 10 microarrays from GEO datasets, 13 literature studies and TCGA-based RNA sequencing data, indicated a reliable diagnostic capacity of miR-21-5p [area under the curve (AUC), 0.887; sensitivity, 0.78% and specificity, 0.79%]. The healthy control group (AUC, 0.926; sensitivity, 0.87% and specificity, 0.82%) demonstrated high diagnostic capacity of miR-21-5p compared with the chronic hepatitis B infection group (AUC, 0.904; sensitivity, 0.75% and specificity, 0.84%). A total of 10 significant enrichment pathways were indicated by KEGG analysis, with cytokine-cytokine receptor interaction exhibiting the highest score. A total of 5 genes, hepatocyte growth factor, forkhead box O1 (FOXO1), thrombospondin 1, estrogen receptor 1 (ESR1) and C-X-C motif chemokine ligand 12 were selected from 39 overlapping genes, according to the PPI network. Target genes were assembled in GO terms associated with 'response to chemical stimulus', 'cell surface' and 'growth factor binding'. In particular, low expression of FOXO1 and ESR1 was associated with miR-21-5p expression. In conclusion, upregulated expression of miR-21-5p may be a functional regulator of the metabolism or apoptosis in HCC and a novel tumor marker for the early diagnosis of HCC.
Introduction
As the second leading cause of cancer-associated mortality, hepatocellular carcinoma (HCC) is one of the most prevalent types of cancer worldwide (1). The incidence rates of HCC have increased over the past two decades, with >40,000 cases occurring in 2017 in the United States alone (2) . The majority of patients with HCC do not receive early treatment and have a poor long-term overall survival (OS) rate, due to malignant features, such as late-stage presentation, metastasis, migration and the lack of HCC symptoms and specific biomarkers (3) . Therefore, the diagnosis of HCC prior to reaching the advanced stage of the disease is imperative, in order to achieve improved treatment outcomes for patients. Currently, α-fetoprotein (AFP) is most widely used diagnostic serological marker for HCC (4) . However, the expression of AFP is not specific to HCC, since it is also expressed in patients with chronic hepatitis B infection without HCC (5) . Nevertheless, AFP-positivity is prevalently manifested in HCC tumors of large size, in the middle to advanced Tumor-Node-Metastasis stage and of high pathological grade compared with AFP-negative status. Therefore, the accuracy of serum AFP for the detection of early-stage HCC is limited (6,7). Molecular targeted drugs Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation have become clinically available, however, only a limited group of patients benefit from this treatment, due to their high price, unclear efficacy and variation in patient response (8, 9) . Therefore, a more precise marker is urgently required for the early detection of HCC and the development of novel therapeutic approaches.
Intracellular communication, gene dysregulation and environmental factors have been indicated to be involved in the extremely complex underlying mechanisms of occurrence, advancement and metastasis of HCC (10, 11) . From a molecular perspective, it has been indicated that multiple genes and cellular pathways take part in the origin and development of HCC (12, 13) . MicroRNAs (miRNAs) are small non-coding endogenous RNAs, ~22 nucleotides in length, serving important roles in proliferation, differentiation, apoptosis, invasion and metastasis, as well as numerous other cellular biological processes (14, 15) . It has been reported that numerous miRNAs exhibit different expression levels in various types of cancer, indicating their future clinical diagnostic value (16) . Among them, miRNA-21 (miR-21) has been indicated to be overexpressed in mammalian cells and has been extensively examined in numerous types of cancer, including esophageal cancer, lung adenocarcinoma, pancreatic adenocarcinoma and tongue squamous cell carcinoma (17) (18) (19) (20) (21) . A number of studies have reported the diagnostic value of elevated expression of miR-21 in HCC compared with healthy controls or patients with chronic hepatitis B infection (22) (23) (24) (25) .
High-throughput technologies, including microarrays and RNA sequencing, have served a crucial role in global gene expression research. The application of gene chip-based gene expression profiles has generated extensive information and provided a theoretical insight into the carcinogenesis of HCC. The Gene Expression Omnibus (GEO), as well as The Cancer Genome Atlas (TCGA), are public data portals regarding numerous cancer and non-cancerous samples, providing an unprecedented source of tumor-associated information for the identification of novel biomarkers. The development of natural language processing (NLP) has also been significant, focusing on the interactions between natural languages and computers and containing a large amount of laboratory and clinical data. The underlying biological mechanism of hub genes can be analyzed through Gene Ontology (GO) functional annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and protein-protein interaction (PPI) network analysis. To the best of our knowledge, the limitation of previous studies regarding miRNA in HCC is their sole focus on serum, plasma, blood or tissue samples (26, 27) .
In the present study, a comprehensive analysis was performed by combining literature studies, KEGG analysis, the GEO database, online software platforms and NLP. In addition, functional annotation and signaling pathway analyses of possible genes were performed with GO enrichment analysis, KEGG analysis and PPI networks. Subsequently, genes with the highest PPI scores were further investigated (Fig. 1) . The aim of the present study was to further understand the underlying pathogenic mechanism and potential clinical value of miR-21-5p in HCC, in order to provide precise diagnostic insights for HCC. Inclusion and exclusion criteria. A study was incorporated when it matched the filter criteria: i) An interpretation of the expression level of miR-21-5p in patients with HCC; ii) number of cases was reported in the study; iii) histopathological examination was used for diagnosis, iv) values of expression available directly or indirectly. Additionally, the following conditions caused the exclusion of a study: i) Duplicate publications; ii) failure to specify the control groups; iii) non-human subjects or, iv) lack of original data, such as review, case report or conference note.
Materials and methods

Meta
Collection and analysis of GEO data. GEO series (GSE) studies were gathered from the GEO database (https://www. ncbi.nlm.nih.gov/geo/). The information obtained included the expression profile of miR-21-5p, the fold-change value in HCC and the type of control sample. There was no restriction on the specific type of control group. Cell line assays or assays not considering expression were excluded. The following information was recorded for GSE chips: Main contributor (first author), publishing year, country, sample type, experiment type, the platform of the GSE chips and the number of patients with HCC and control patients. True positive (TP), false positive (FP), false negative (FN), true negative (TN) rates and area under the curve (AUC) were also recorded. All the expression values of miR-21-5p from GEO data were log2 scaled. The level of expression of miR-21-5p between patients with HCC and controls was compared using GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA).
Collection and clinical parameter analysis of TCGA data. TCGA miR-seq data was downloaded from Firebrowse (http://firebrowse.org/), for the entry of liver HCC ('LIHC') on April 17th, 2017. Subsequently, the data was manipulated by SPSS 21.0 (IBM Corp., Armonk, NY, USA). Clinical parameters, including age, sex, grade, stage, vascular invasion, history of primary risk factors, hepatitis B virus infection and histological type, were visualized using GraphPad Prism 5.0.
Comprehensive meta-analysis based on studies from literature, GEO and TCGA. Consistent data elements for the integrated meta-analysis were extracted. Following the input of accuracy data, including TP, FP, FN and TN, of each study into MetaDiSc 1.4, the integrated value of sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and AUC was calculated (28) . Receiver operator characteristic (ROC) curve was applied to evaluate the overall diagnostic accuracy. AUC was calculated for the combined pool of comprehensive data. Depending on the use of a healthy control group or chronic hepatitis B infection control group from the extracted studies, two additional analyses were performed in addition to the meta-analysis of the literature.
Subgroup analyses. In order to evaluate the diagnostic capacity of miR-21-5p from different experimental methods and sample types and figure out the heterogeneity, four subgroup analyses were performed. Diagnostic efficiency of each subgroup was performed with MetaDiSc 1.4.
Potential target gene collection and bioinformatics investigation
Collection of potential target genes. Genes were selected when identified by >3 of the 14 online software packages Figure 1 . Flow chart of the study protocol. HCC, hepatocellular carcinoma; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus; GO, Gene Ontology; PPI, protein-protein interaction network; NLP, Natural Language Processing; sROC, summary receiver operating characteristic. (46) by RT-qPCR (miRanda, mirbridge, miRWalk, Microt4, mirTarbase, PITA, miRDB, RNA22, miRNAMap, miRMap, RNAhybrid, PicTar, Targetscan and PolymiRTS). Overlapping genes were identified by the combination of the predicted genes from 14 online software packages, TCGA, GEO and NLP. Overlapping genes were considered to be possible target genes of miR-21-5p.
Functional annotation. GO functional annotation were performed and visualized by Bingo plug-in units from Cytoscape 3.5.0 (Cytoscape, Seattle, WA, USA) (29) . GO pathway enrichment analysis consists of three components: i) Biological process (BP); ii) molecular function (MF), and iii) cellular component (CC). A BP term with P<0.005 was considered to be statistically significant. P<0.05 was denoted as the cut-off criteria for CC and MF terms. The functional annotation data were extracted from the downloaded files on August 31th, 2018.
PPI network construction and signal pathway analyses.
A bioinformatics database called Search Tool for the Retrieval of Interacting Genes/Proteins (STRING 10.5; http://www. string-db.org) was applied to establish a gene interaction network and excavate notable pathways associated with the potential target genes of miR-21-5p (30) . KEGG pathways were determined from the Analysis module and the complete PPI network was drawn on August 31th, 2018. Each internal node in the PPI map represents one potential gene, while the edges between genes indicate a regulatory connection between the genes. These connections can be vividly synthesized and scored. The higher the score, the closer the association between the genes. Genes with high scores may occupy a critical position in the network or act Table I . Continued. 
Results
Meta-analysis of the literature regarding the clinical role of miR-21-5p
. By retrieving and complying with the inclusion and exclusion criteria, 13 eligible studies were incorporated into the meta-analysis of the literature (33-39) ( Table I ). The flowchart indicated in Fig. 2 illustrates the selection and retrieval process. A total of 7 studies were performed in China, 3 in Egypt and 3 in Japan. The literature data were entered into MetaDiSc 1.4 and it was indicated that there was significant heterogeneity in the pooled estimates of SEN, SPE, PLR, NLR, and DOR, P<0.05. Therefore, the random-effects model was used. The pooled sensitivity and specificity were 0.81 (95% confidence interval; (CI), 0. Fig. 3B and C).
Collection and analysis of GEO data. Gene expression in HCC samples and corresponding adjacent para-tumorous liver tissues were compared. A total of 10 GSE chips from GEO datasets were available for the comprehensive meta-analysis (40-46) (Table I) . A total of 8 chips were sequenced by array, while 2 chips were analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). With the exception of one chip that used serum, the samples for the other 9 chips were tissue samples. Expression differed among the chips. Significant differences were observed in 5 GSE chips, which indicated increased expression of miR-21-5p in HCC tissues compared with the corresponding adjacent non-cancerous tissues (P<0.05). The results were as follows: 2.55±0.0299 vs. Fig. 5E ). No significant differences in miR-21-5p expression level were associated with vascular invasion, stage, age or sex (Fig. 5F-I ). Integrated diagnostic value. A total of 24 studies, including 10 microarrays from GEO datasets, 13 literature studies and TCGA-based RNA sequencing data were included for the comprehensive meta-analysis. Significant heterogeneity was identified in all five pooled effects (SEN, SPE, PLR, NLR and DOR) by the Q and I 2 tests (all I 2 >50% and P<0.05). Accordingly, a random-effects model was employed. As presented in Table II, the Fig. 3D) . Table III) . The value of SEN, SPE, PLR and DOR were increased in the serum/plasma subgroup compared with the tissue subgroup. AUC values from the sROC of the RT-qPCR subgroup, array subgroup, tissue subgroup and serum/plasma subgroup were 0.896, 0.822, 0.826 and 0.902, respectively (Table III ; Fig. 3 ). Nevertheless, no publication bias existed in the meta-analysis according to Deeks test. (P=0.877; Fig. 6 ).
Potential target gene collection and bioinformatics analysis Collection of prospective target genes.
A total of 48,446 target genes were identified from 14 prediction software packages and genes had to be identified ≥3 times to be regarded as potential target genes of miR-21-5p. Reduced-expression genes assembled from TCGA and GEO and genes selected from NLP were integrated to identify overlapping genes. Out of the 10,911 potential target genes, 1,123 reduced-expression genes from TCGA, 2,956 reduced-expression genes from GEO and 1,800 genes were analyzed for intersection. This resulted in 39 target genes attained for the following bioinformatics analyses.
Functional annotation and signal pathway analyses. The GO annotation system in DAVID identified the 39 target genes significantly involved in the following biological processes: 'response to chemical stimulus' (GO:0042221; P=2.08x10 -11 ), 'regulation of MAPKKK cascade' (GO:0043408; P=1.68x10 -10 ) and 'regulation of intracellular protein kinase cascade' (GO:0010627; P=2.39x10 -10 ) (Table IV; Fig. 7 ). As for cellular components, target genes were concentrated in terms of the 'cell surface' (GO:0009986; P=9.04x10 -7 ), 'interleukin-6 receptor complex' (GO:0005896; P=1.57x10 -5 ) and 'plasma membrane part' (GO:0044459; P=8.66x10 -5 ) (Table IV ; Fig. 8 ). The ten significant GO terms were exhibited for BP, CC and MF.
Genes were prominently accumulated in 3 molecular functions, including 'growth factor binding' (GO:0019838; P=2.10x10 -7 ), 'caffeine oxidase activity' (GO:0034875; P=3.53x10 -5 ) and 'oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor' (GO:0033695; P=3.53x10 -5 (Table IV ; Fig. 9 ). Additionally, five pathways took precedence in KEGG pathway analysis (FDR<0.01): 'Cytokine-cytokine receptor Fig. 11Be ), respectively. The results of correlation analysis between the hub genes (HGF, FOXO1, THBS1, ESR1 and CXCL12) and miR-21-5p were as follows: (R=0.01851; P=0.08995; Fig. 11Ca ), (R=-0.3467; P=0.0147; Fig. 11Cb ), (R=0.4334; P=0.0019; Fig. 11Cc ), (R=-0.4129; P=0.0032; Fig. 11Cd ), (R=0.3830; P=0.0066; Fig. 11Ce ), respectively.
Discussion
The pathogenesis of HCC has been extensively investigated and there is a consensus that miRNAs may act as vital In previous studies, miR-21-5p diagnostic ability has been reported, due to an increased level of expression being correlated with HBV infection, advanced tumor grade, history of risk factors and advanced pathological stage. HBV infection is considered to be a major risk factor for hepatocarcinogenesis (55) . However, the underlying mechanism of miRNAs with HBV-associated HCC requires further investigation. Xie et al have identified certain factors contributing to HCC, including long-term HBV infection, high levels of HBV replication, HBV genotype, specific HBV variants, HBV integration and HBV coding proteins (56). Xie et al (57) have summarized the change in expression of numerous miRNAs in HBV infection and have demonstrated the upregulation of miR-21 expression in HBV-associated HCC. In the present study, a more accurate diagnostic effect of miR-21-5p was demonstrated in distinguishing patients FKHR) has been reported to be the target gene of miR-21 in various types of tumor, including large B-cell lymphoma, pancreatic ductal adenocarcinoma and glioblastoma (58) (59) (60) . The aforementioned studies have identified that overexpression of miR-21 decreased the level of FOXO1. Dong et al have claimed that FOXO1 inhibits the invasion and metastasis of HCC (61) . However, the specific function of FOXO1 in HCC has not yet been determined. The role of estrogen receptor 1 (ESR1) in breast cancer has been investigated, but also its clinical relevance in prostate, endometrial and other types of cancer (62) . The expression of ESR1 can predict the grade and stage of non-muscle-invasive bladder carcinoma have been reported (63) . Dou et al have stated that methylation of ESR1 in HBV-associated HCC may be affected by HBV (64) . A study by Hishida et al (65) considered ESR1 as a candidate tumor suppressor gene in HCC. THBS1 may serve a role as an inhibitor of tumor growth, cell migration and neovascularization in lung cancer (66) . From the functional annotation analysis in the present study, the hub genes participated in various processes, including 'response to chemical stimulus', 'cell surface' and 'growth factor binding'. It was speculated that miR-21-5p expression may be involved in metabolism or apoptotic processes of HCC.
While the present study provides additional evidence supporting the use of miR-21-5p to diagnose HCC, there are limitations that should be acknowledged. Firstly, significant heterogeneity was unavoidable. As noted in the meta-analysis, samples from serum or plasma and the use of RT-qPCR were more precise in diagnosing HCC compared with studies using tissues or the array method, which indicated that the sample type and experiment type may influence the accuracy of diagnosis. Secondly, variation in sample size, sex ratio and age may also have contributed to heterogeneity. Thirdly, miR-21-5p expression levels in patients with HCC from different geographic locations and times may also have an effect. In addition, the results were based solely on data from a range of databases. Therefore, verification experiments to reveal the underlying molecular mechanisms of miR-21-5p are required to confirm the results of the present study, particularly the pathway and functional analysis of miR-21-5p.
In conclusion, an accumulation of data from GEO datasets, TCGA, NLP and literature databases was performed to describe the application potential of miR-21-5p in HCC. Using bioinformatics methods, including pathway enrichment analyses, functional annotation by GO and correlation analysis, the underlying molecular mechanism of miR-21-5p was investigated. Subgroup analyses for different types of experiment and sample were also conducted, in order to compare the diagnostic capacity and identify sources of heterogeneity. FOXO1 and ESR1 were negatively correlated with upregulation of miR-21-5p expression. The highest enriched pathway (cytokine-cytokine receptor interaction) requires further investigation. Prospective studies with large cohorts are required to verify the present study's findings, and to clarify the underlying molecular mechanism of miR-21-5p in HCC.
